Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Daycare and siblings increase likelihood of contracting respiratory syncytial virus and rhinovirus

Daycare attendance and siblings are associated with viral-induced wheezing in children. Pre-existing immunologic factors may influence the expression of viral infections in infancy, and in turn, recurrent infections may influence the development of immune responses.

17 Apr 2004

GlaxoSmithKline files asthma treatment drug for approval in Japan

GlaxoSmithKline plc announced today that it has filed SeretideTM DiskusTM for approval to the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of asthma in adults and children.

16 Apr 2004

Unflued gas heaters linked to asthma attacks

Professor Pilotto said that while previous research has shown a link between unflued gas exposure and asthma, the results of this study were more conclusive as they were based on a randomised control trial of unflued gas heater replacement.

14 Apr 2004

Don't let the bed bugs bite

A robust new breed of blood-sucking bed bugs are on the rise in Britain, and experts fear the “super” pests cannot be killed.

14 Apr 2004

Houston blows poor air not just hot air

A study by a Texas A&M University researcher shows that Houston has wild fluctuations of air pollution – far above acceptable national standards – and these could pose a serious health risk to the city's inhabitants unless controls are quickly started.

14 Apr 2004

A new system of health and wellbeing

Hands up who goes to the doctor when they are feeling well? Hands up who goes to the doctor just to chat about how they can stay well? The fact is most of us drag ourselves off to the doctor only when there are signs of trouble, when we are feeling sick.

14 Apr 2004

More Americans allergic to seafood than any other food

A new study released today at the American Academy of Allergy, Asthma & Immunology annual conference shows that food allergies are a much more pervasive health challenge than once thought. About 11 million people -- roughly 1-in-25 Americans -- are now believed to be affected by one or more food allergies, a disease triggered by the ingestion or contact with certain foods that may cause life-threatening reactions, or anaphylaxis, according to The Food Allergy & Anaphylaxis Network (FAAN), a co-investigator of the nationwide survey.

13 Apr 2004

Compound in ventolin inhalers could make asthma worse

A chemical used in the leading brand of asthma inhaler could actually make the allergy worse, say scientists. They fear a compound in Ventolin inhalers may react with steroids used to prevent attacks.

13 Apr 2004

Allergies cost UK £1 billion per annum

Researchers from the Universities of Edinburgh and Aberdeen and St George’s Medical School in London say one in five children and adults in Britain suffer from allergies, with annual health services treatment bill running at £1billion. They call for more allergy specialists to meet the increased demand.

13 Apr 2004

Household molds trigger allergic rhinitis

April showers can increase the amount of mold found inside and outside the home. Along with pollens from trees, grasses, and weeds, molds are an important trigger of allergic rhinitis, affecting nearly 40 million Americans, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).

12 Apr 2004

Research shows no association between whooping cough vaccine and asthma

Parents who may be concerned by a scare over the side effects of the whooping cough vaccine will be reassured by a new study involving thousands of children. The Department of Health advice that babies should be vaccinated against whooping cough (pertussis) at the age of two, three and four months has been questioned by some scientists who have suggested a link with asthma and allergies.

1 Apr 2004

GlaxoSmithKline and Theravance to form strategic alliance

GlaxoSmithKline plc (GSK) and Theravance, Inc., a privately-held pharmaceutical company, announced today that they have entered into an innovative broad-based strategic alliance to develop and commercialise novel medicines across a variety of important therapeutic areas, including bacterial infection, respiratory, urinary incontinence and gastrointestinal.

31 Mar 2004

Air pollution effects Cystic Fibrosis Sufferers

University of Washington (UW) researchers have shown for the first time that air pollution has adverse effects on people with cystic fibrosis (CF). The research results are published in the April 1 edition of the American Journal of Respiratory and Critical Care Medicine.

29 Mar 2004

Asthma study turns up new information on viral infections

Researchers know that viral infections can exacerbate asthma and, in turn, make people with the condition more sensitive to environmental exposures such as endotoxin. But how viral infections contribute to this sensitivity in airway cells has not been clear. A recent study led by investigators from the University of Iowa Roy J. and Lucille A. Carver College of Medicine and the Veterans Affairs Medical Center (VAMC) in Iowa City shows, for the first time, that viral infections may increase environmental sensitivity in lung epithelial (surface) cells by changing expression of receptors on those cells.

25 Mar 2004

Olopatadine nasal spray shown to minimise hay fever

Alcon announced today results from a Phase III clinical trial demonstrating that olopatadine nasal spray, a nasal formulation of its market leading ophthalmic anti-allergy product, Patanol(R) ophthalmic solution, reduced seasonal allergic rhinitis (SAR) symptoms compared to placebo.

22 Mar 2004

FDA approves new chewable formulation of Zyrtec® aimed at young allergy sufferers

Pfizer Inc and UCB Pharma today announced the approval of a new chewable formulation of Zyrtec® (cetirizine HCl) for the treatment of seasonal and perennial allergic rhinitis (inflammation of the nasal passages) and chronic idiopathic urticaria (itching and hives of unknown causes) in children aged two years and older. The approval by the US Food and Drug Administration makes Zyrtec the first and only prescription antihistamine available in both syrup and chewable form.

22 Mar 2004

Forward step in treatment of Allergic Rhinitis

Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company’s lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.

22 Mar 2004

Japanese study raises concerns for childhood health issues

The number of children suffering from mental disorders and health problems such as allergies and asthma has risen sharply over the past decade in this country. The United States and European countries are also facing the increasingly serious problems of premature births and childhood obesity, in addition to allergic reactions. Many experts say the rise in health problems involving children is related to the use of chemicals in our daily lives and the impact of medical treatment provided to the children's mothers.

22 Mar 2004

Government, industry, and academia focus on obesity

Amid shifting scientific data on nutrition and obesity, experts from government, industry, and academia converged on Harvard Medical School last week to discuss obesity's causes and how to craft a coherent public nutritional message.

22 Mar 2004